国际麻醉学与复苏杂志   2013, Issue (7): 6-6
    
帕瑞昔布钠预先干预对经前期综合征模型大鼠的作用
陈冬婷, 古妙宁, 卢纯华, 梁佳妮, 张志杰, 赵振龙, 孙艺娟, 谭曼玲1()
1.南方医科大学南方医院麻醉科
The effects of pre-intervention parecoxib sodium on premenstrual syndrome model rats.
 全文:
摘要:

目的 研究帕瑞昔布钠预先干预对经前期综合征(premenstrual syndrome,PMS)模型大鼠的作用。 方法 36只Wistar大鼠依阴道涂片法确定大鼠动情周期,分别将处于动情后期的大鼠采用完全随机分组方法分为:正常组(C组),模型组(M组),模型+帕瑞昔布钠组(A组)。采用慢性束缚应激法复制PMS模型,持续7 d。造模第5~7天,A组给予帕瑞昔布钠肌注0.72 mg/kg。造模成功后,于第8天处死大鼠。免疫组化检测大鼠子宫内膜组织环氧化酶-2(cycloxygenase-2, COX-2)、前列腺素E2 (prostaglandin E 2, PGE2)的表达,Western blot法检测大鼠大脑海马组织COX-2、PGE2的表达。 结果 ① M组和A组大鼠子宫内膜COX-2表达高于C组,差异有统计学意义(P<0.01);与M组(0.46±0.11)比较, A组(0.31±0.12)子宫内膜COX-2表达显著降低32%(P<0.05)。 ② M组和A组子宫内膜PGE2表达较C组显著增加(P<0.01);与M组(0.49±0.08)比较,A组(0.39±0.09)子宫内膜PGE2表达显著降低18.9%(P<0.05)。③ M组和A组大鼠海马组织COX-2表达高于C组,差异有统计学意义(P<0.01);与M组(0.91±0.03)比较,A组(0.72±0.05)大鼠海马组织COX-2表达显著降低20.8%(P<0.05)。④ M组和A组大鼠海马组织PGE2表达较C组显著增加(P<0.01);与M组(1.13±0.01)比较,A组(0.92±0.06)大鼠海马PGE2表达显著降低18%(P<0.05)。 结论 帕瑞昔布钠预先干预能降低PMS模型大鼠子宫内膜及大脑海马部位COX-2、PGE2的表达。

关键词: 帕瑞昔布钠; 经前期综合征; 环氧化酶-2; 前列腺素E2
Abstract:

Objective To investigate the effects of pre-intervention parecoxib sodium on premenstrual syndrome(PMS) model rats. Methods 36 rats were randomly divided into 3 groups according to the results of Vaginal secretion smear, the normal group (group C), the model group (group M) , and the pre-intervention parecoxib sodium group (group A). PMS models were prepared by chronic restraint stress, which persist for 7 d. Group A was pre-administered parecoxib sodium0.72 mg/kg from the fifth day to the seventh day. All the rats were sacrificed at the eighth day. Then we applied immunohistochemical to detect the COX-2 and PGE2 expression on rat endometrium, and Western blot to detect the COX-2 and PGE2 expression on rat hippocampus. Results ① COX-2 expression on rat endometrium of group M and group A was significantly higher than group C(P<0.01); COX-2 expression on the endometrium of group A (0.31±0.12) was 32% lower than group M(0.46±0.11)(P<0.05). ② PGE2 expression on rat endometrium of group M and group A was significantly higher than group C(P<0.01); PGE2 expression on endometrium of group A(0.39±0.09)was 18.9% lower than group M(0.49±0.08)(P<0.05). ③ COX-2 expression on hippocampus of group M and group A was significantly higher than group C(P<0.01); COX-2 expression on hippocampus of group A(0.72±0.05)was 20.8% lower than group M(0.91±0.03)(P<0.05). ④ PGE 2 expression on hippocampus of group M and group A was significantly higher than group C(P<0.01), COX-2 expression on hippocampus of group A(0.92±0.06)was 18% lower than group M(1.13±0.01)(P<0.05). Conclusions Parecoxib sodium pre-intervention could decrease COX-2 and PGE2 expression on endometrium and hippocampus in premenstrual syndrome model rats.

Key words: parecoxib sodium; PMS; COX-2; Prostaglandin E 2